Express News | Amarin Highlights Recent Data Presented At ACC.25 Evaluating Mechanistic Effects Of Eicosapentaenoic Acid In Lp(a)-Enriched Plasma And In Combination With GLP-1 Agonist
Trump's Medical Tariffs Could Significantly Hurt These European Healthcare Firms
Top Small-cap Value Stocks According to SA Quant
European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading
Sector Update: Health Care Stocks Mixed Late Afternoon
Amarin Shareholders Calls for Strategic Review
Express News | Amarin Shareholders Radoff and Torok: Amarin Board Should Immediately Announce, Run Strategic Review Maximizing Value for All Shareholders
Amarin Announces Additional in Vitro Data With EPA to Be Presented
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
Amarin's Mixed Fortunes: Navigating U.S. Competition and European Growth Opportunities
Why Investors Shouldn't Be Surprised By Amarin Corporation Plc's (NASDAQ:AMRN) 26% Share Price Plunge
AMRN's Q4 Earnings Lag Estimates, Stock Down on Ratio Change Plan
Amarin Corporation Reports Q4 Financial Results and Strategic Moves
Amarin Corporation's Earnings Call: A Mixed Outlook
European Equities Traded in the US as American Depositary Receipts Lower Wednesday
Express News | Amarin Corporation Shares Are Trading Lower. The Company Reported Q4 Financial Results
Earnings Call Summary | Amarin(AMRN.US) Q4 2024 Earnings Conference
Amarin Plans 1-for-20 ADS Ratio Adjustment
Amarin Drops Despite Q4 Beat Amid ADS Ratio Change
Amarin Beats Top-line and Bottom-line Estimates; Initiates FY25 Outlook